Terra

@TerraBioApp

Scalable cloud platform for biomedical researchers to access data, run analysis tools, & collaborate. A product by the Broad Institute, Microsoft, and Verily.

Cambridge, MA Terra.bio Joined January 2019

629 Following 1.9K Followers 642 Posts

Latest posts 5

Pinned post

Terra @TerraBioApp Jul 8, 2021

New 2min video explains why #LifeSciences research is moving to the cloud and how Terra helps you focus on your science youtube.com/watch?v=w9mGcv… #Bioinformatics #CloudComputing

www.youtube.com Terra in a nutshell Terra is a scalable cloud platform for biomedical researchers to ac...

Terra @TerraBioApp Sep 20, 2024

Learn how Terra meets the evolving security requirements of NIH's Genomic Data Sharing Policy, set to take effect by January 25, 2025: terra.bio/nihs-updated-g…

terra.bio Are you compliant with NIH’s updated Genomic Data Sharing policy? Terra can help! - Terra On July 25, 2024, the National Institutes of Health (NIH) issued updated guidance to the Genomic Data Sharing Policy stating that...

Terra @TerraBioApp Jan 27, 2023

@C_Loreth, Associate Director of Scientific Impact at the Broad Institute Data Sciences Platform, announcing the launch of Terra on @Azure this week at @FoGenomics

#TerraOnAzure, #FoG2023

Terra @TerraBioApp Jan 25, 2023

📣We're thrilled to announce that Terra on @Azure is now open for preview!
terra.bio/terra-on-azure…

terra.bio Introducing Terra on Azure - Terra We have been working closely with our partners at Microsoft to expand Terra to a multi-cloud offering. We are now launching the preview phase of Terra on Azure. Sign up today to become an early...

Terra @TerraBioApp Dec 22, 2022

From high-throughput processing of exome data with GATK to variant analysis with seqr, this neurodevelopment study leveraged the cutting-edge infrastructure of @useAnVIL powered by Terra
terra.bio/paper-spotligh…

terra.bio Paper Spotlight: Phenotype and genetic analysis of data collected within the first year of NeuroDev... This study used GATK and seqr in Terra to identify variants likely to cause neurodevelopmental disorders, based on exome data from family trios.